Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$163K Hold
3,388
0.08% 130
2025
Q4
$164K Sell
3,388
-90
-3% -$4.46K 0.09% 129
2025
Q3
$164K Hold
3,478
0.1% 127
2025
Q2
$168K Sell
3,478
-50
-1% -$2.56K 0.1% 134
2025
Q1
$196K Sell
3,528
-6,248
-64% -$338K 0.13% 123
2024
Q4
$471K Buy
9,776
+5,568
+132% +$283K 0.15% 116
2024
Q3
$243K Sell
4,208
-100
-2% -$5.4K 0.15% 112
2024
Q2
$209K Hold
4,308
0.13% 127
2024
Q1
$209K Buy
4,308
+30
+0.7% +$1.47K 0.13% 125
2023
Q4
$213K Buy
+4,278
New +$209K 0.15% 118

Other funds holding SNY

Hara Capital's SNY Position: Q1 2026 in Review

Hara Capital held its Sanofi (SNY) position steady in Q1 2026 at 3,388 shares worth $163K. The position accounts for 0.08% of the portfolio, ranked #130.

Hara Capital first reported a position in SNY in Q4 2023 and has held it in 10 quarters since. The position peaked at $471K in Q4 2024. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Hara Capital held 3,388 shares of Sanofi worth $163K as of Q1 2026.
  • Hara Capital left its Sanofi share count unchanged in Q1 2026.
  • Sanofi made up 0.08% of Hara Capital's portfolio in Q1 2026, its #130 holding.
  • Hara Capital first reported a position in Sanofi in Q4 2023 and has held it in 10 quarters since.
  • Hara Capital's Sanofi position peaked at $471K in Q4 2024.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Hara Capital's 13F filing for Q1 2026, filed 14 May 2026.